Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.73% |
| 2 | Technology | 14.98% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Kimbell Royalty Partners
KRP
$1.48B
| $1.7M | ﹤0.01% |
86,755
+36,040
| +71% | +$792K |
|
2352
Turkcell
TKC
$4.68B
| $1.7M | ﹤0.01% |
353,019
-686,200
| -66% | -$3.63M |
|
2353
CarParts.com
PRTS
$43.7M
| $1.7M | ﹤0.01% |
109,610
+1,720
| +2% | +$25.1K |
|
|
GES
2354
DELISTED
Guess Inc
GES
| $1.7M | ﹤0.01% |
75,000
-142,954
| -66% | -$3.24M |
|
2355
Masco
MAS
$14.1B
| $1.7M | ﹤0.01% |
+46,300
| New | +$1.78M |
|
|
TIVO
2356
DELISTED
Tivo Inc
TIVO
| $1.7M | ﹤0.01% |
136,135
+38,900
| +40% | +$503K |
|
|
NVTR
2357
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.7M | ﹤0.01% |
77,100
+49,700
| +181% | +$956K |
|
|
CIVI
2358
DELISTED
Civitas Solutions, Inc.
CIVI
| $1.7M | ﹤0.01% |
114,935
-5,465
| -5% | -$86.2K |
|
|
ALDR
2359
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.69M | ﹤0.01% |
101,500
-333,300
| -77% | -$6.02M |
|
2360
Hallador Energy
HNRG
$670M
| $1.69M | ﹤0.01% |
271,256
+54,456
| +25% | +$344K |
|
|
BMCH
2361
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.69M | ﹤0.01% |
+90,400
| New | +$1.96M |
|
|
ICAD
2362
DELISTED
iCAD Inc
ICAD
| $1.68M | ﹤0.01% |
577,960
+68,200
| +13% | +$202K |
|
2363
ASE Group
ASX
$77.3B
| $1.68M | ﹤0.01% |
347,806
-246,454
| -41% | -$1.17M |
|
|
OXFD
2364
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.68M | ﹤0.01% |
103,300
+82,242
| +391% | +$1.18M |
|
|
ASCMA
2365
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.68M | ﹤0.01% |
947,100
+10,900
| +1% | +$28K |
|
|
ACET
2366
DELISTED
Aceto Corp
ACET
| $1.67M | ﹤0.01% |
739,000
+233,400
| +46% | +$746K |
|
|
NITE
2367
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $1.67M | ﹤0.01% |
+81,700
| New | +$1.68M |
|
2368
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.66M | ﹤0.01% |
217,203
-177,378
| -45% | -$1.19M |
|
2369
Lisata Therapeutics
LSTA
$9.02M
| $1.66M | ﹤0.01% |
18,724
+5,620
| +43% | +$461K |
|
|
TCON
2370
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $1.66M | ﹤0.01% |
4,041
+441
| +12% | +$204K |
|
2371
iShares Select Dividend ETF
DVY
$23.5B
| $1.66M | ﹤0.01% |
16,600
+11,000
| +196% | +$1.1M |
|
2372
Investar Holding Corp
ISTR
$415M
| $1.66M | ﹤0.01% |
61,648
+4,248
| +7% | +$116K |
|
|
AXAS
2373
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.66M | ﹤0.01% |
35,515
+4,450
| +14% | +$218K |
|
|
MR
2374
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.65M | ﹤0.01% |
92,605
-97,362
| -51% | -$2.23M |
|
2375
Talphera
TLPH
$66.4M
| $1.65M | ﹤0.01% |
21,435
-3,395
| -14% | -$218K |
|
Similar funds
Renaissance Technologies's Q3 2018 Portfolio in Review
As of Q3 2018, Renaissance Technologies held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Renaissance Technologies's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Renaissance Technologies added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Renaissance Technologies's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Renaissance Technologies fully exited Apple in Q3 2018, selling an estimated $707M.
- Renaissance Technologies's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Renaissance Technologies opened 508 new positions and closed 410 in Q3 2018.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.